Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
about
Concise review: bone marrow autotransplants for liver disease?Systematic review: the effects of autologous stem cell therapy for patients with liver diseaseBone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver diseaseGranulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice.Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemThe impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.Regenerative medicine as applied to general surgeryAssessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian studyGranulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failureRegenerative medicine as applied to solid organ transplantation: current status and future challenges.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.Immunological basis of stem cell therapy in liver diseases.Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseasesUse of stem cells for liver diseases-current scenario.Model systems and clinical applications of hepatic stem cells for liver regeneration.Bone marrow stem-cell therapy for genetic and chronic liver diseases.IL - 10 secreted by Mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.Progress in stem cell-based therapy for liver disease.Liver regeneration - mechanisms and models to clinical application.¹⁹F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells.Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial.Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis.Hepatic regenerative potential of mouse bone marrow very small embryonic-like stem cells.Effect of bone marrow mesenchymal stem cell transplantation on acute hepatic failure in rats.In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice.Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury.Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.Superior Potential of CD34-Positive Cells Compared to Total Mononuclear Cells for Healing of Nonunion Following Bone Fracture.Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option.CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.
P2860
Q27010009-87FDA50A-F372-466C-920F-F6BC57B868A7Q27024968-0DE74C41-512D-42F7-8D71-BA01949C4FFCQ33818431-566F0332-592E-494D-8D33-E4668DB506E9Q33822241-E5494E5F-EF36-43D4-BC96-2C51D84130D0Q33900601-EA45293F-2F6D-48F2-AE4E-235FC4AE2712Q34234307-5AFA53F8-ACCD-45B2-9B00-F81E2A947ADAQ34306742-0B6F081A-A9F6-4296-B759-EC12C217D101Q35203746-82A51B06-B928-4336-BAD5-B1B143A7A2EDQ35786513-757B6C11-22A9-4FE0-955F-960D82342C9CQ35892487-6055D223-5970-4C00-BDA1-2CFA2B4B9301Q36633041-5CC56D59-8EB9-4098-B55E-B04DBBB788ECQ36637720-9837FCE8-7ED9-44AA-95B0-EA714D01EAF9Q37278992-FC346F16-62F0-4698-B0E3-79705B0C6901Q38159684-E8F570B5-0C08-4911-9318-0EFD68F07D68Q38223210-8B5E3615-A79D-427C-A99F-D449B6D16F83Q38291498-F543BB08-6D9A-4FD1-BAEB-9F33078E853BQ38371445-B68814DF-2AE5-46B8-A503-EBE973692364Q38552153-F8315C5E-7DF5-461B-A270-F330D593F643Q38552426-9E517D2D-BB8E-4E11-8259-79EFD8B9D18FQ38611853-9A604C66-BC4E-4661-9203-4990BE306E8BQ38675565-586367D8-E49C-4E93-AB5E-744205E01B33Q38820953-48AB89C2-8FD9-4A9F-B900-177E7C694A3FQ38836460-B748D7C1-CD06-4322-BF32-AB968F5A9375Q38879963-49086397-21D8-401C-8DC8-1D00D72F64DFQ39574532-991BE6C9-BB39-4FB5-8C68-187D2B5F1AD5Q40219189-35FFDCAD-537B-4119-A7DC-B2567FEDE31AQ40705537-427EAA43-F4D4-4E3A-850A-EDB4AA0BF56FQ41643401-6115424E-C20A-43DF-AEC0-3B0B6EAB7BA6Q41754256-61A224EC-27DB-49B3-B3CE-5E7FD7098C48Q41922753-4628D6F2-5743-4F5E-88F4-4CEAEB63C10AQ42211604-A189CF41-6BAC-4CDE-8F13-9A4C262F27D3Q42708757-D39C4BAA-3A58-4528-B99F-E8126AB8303CQ46177862-C342F844-14F3-4D5D-A746-C70A6E6B2DA1Q46700815-6A7ADCBE-9D14-4C5C-82E3-EFD75D2BB11BQ47109230-DA628992-C8C3-4F89-BA7C-36212218D641Q51737339-456E194B-9E3D-4F9D-9A9C-7EE3CA1633C9Q52568315-7CF6341A-92ED-4441-958E-87052FE0207CQ53057906-9B72C24D-26E5-4453-8596-E1FCD48CE51CQ53072949-FF5364DF-2FB5-4336-9495-4675B3C5FDF4Q53124908-EE92767A-C2E3-4038-BE32-731F707488AA
P2860
Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@en
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@nl
type
label
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@en
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@nl
prefLabel
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@en
Autologous hematopoietic stem ...... -stage chronic liver diseases.
@nl
P2093
P2860
P356
P1433
P1476
Autologous hematopoietic stem ...... d-stage chronic liver diseases
@en
P2093
Abeer Bahnassy
Cheryl Vigen
Elizabeth Huttinger
Eman Medhat
Hosny Salama
Mohamed Mostafa
Samah Loutfy
Sameh Shalaby
P2860
P304
P356
10.3727/096368910X514314
P577
2010-06-29T00:00:00Z